Conventional Platelet-Rich Plasma Versus Concentrated Bone Marrow Stem Cell Injections for Osteoarthritis of the Knee
A Randomized, Single-Blinded, Controlled Trial Comparing Conventional Platelet Rich Plasma (PRP) to Concentrated Bone Marrow Aspirate (BMAC) for Osteoarthritis of the Knee
The Mayo Clinic in Florida is conducting a trial comparing two treatments for osteoarthritis of the knee: injections of bone marrow aspirate concentrate (BMAC) stem cells taken from the patient’s hip bone, and injections of platelet-rich plasma drawn by IV. Both treatments are delivered directly into the knee. Follow up will be needed at 1 week, 6 weeks, 6 months, and 12 months after the injections, plus X-rays before the treatment and at 12 months.
- Be 18 years of age and older
- Have a diagnosis of osteoarthritis in both legs and pain in one knee meeting certain grades
- Subjects must have previously tried 6 weeks of one of the following conservative treatments: Activity modification, weight loss, physical therapy, anti-inflammatory, or injection therapy
- Not be pregnant or breastfeeding
THE STUDY INVOLVES:
- Prescreening tests to confirm eligibility of the patient to participate.
- Recovery of the plasma or bone marrow aspirate. Each require a short hospital visit, though the bone marrow aspirate is a more complex procedure.
- Follow up will be needed at 1 week, 6 weeks, 6 months, and 12 months after the injections, plus X-rays before the treatment and at 12 months.
LOCATIONS AND CONTACTS:
The study site is at the Mayo Clinic in Jacksonville, FL. Map.
Shane Shapiro, MD | (904) 953-2496 | [email protected]
Or go online: